Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice

Human Molecular Genetics

Volumn 17, Issue 15, 2008, Pages 2345-2356

  Sun, Ying ^a,b   Witte, David P ^a,b   Ran, Huimin ^a   Zamzow, Matt ^a   Barnes, Sonya ^a   Cheng, Hua ^c   Han, Xianlin ^c   Williams, Michael T ^b   Skelton, Matthew R ^b   Vorhees, Charles V ^b   Grabowski, Gregory A ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; CD68 ANTIGEN; CYSTEINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLOBOTRIAOSYLCERAMIDE; GLYCOPROTEIN; GLYCOSPHINGOLIPID; HYDROLASE; HYDROXY FATTY ACID; LACTOSYLCERAMIDE; PROSAPOSIN; PROTEIN PRECURSOR; SAPOSIN A; SAPOSIN B; SAPOSIN C; SAPOSIN D; SPHINGOLIPID ACTIVATOR PROTEIN; SULFATIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; EXON; GENE MUTATION; HOMEOSTASIS; HOMOZYGOTE; INFLAMMATION; KIDNEY; LAMELLAR BODY; LEUKODYSTROPHY; LIPID DEGRADATION; LIPID METABOLISM; LIPID STORAGE; MALE; MICROGLIA; MOTONEURON; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCIATIC NERVE; SPINAL CORD; TREMOR; ULTRASTRUCTURE;

ANIMALS; BRAIN; FEMALE; GLUCOSYLCERAMIDASE; GLYCOSPHINGOLIPIDS; HOMOZYGOTE; KIDNEY; MALE; MICE; MICE, KNOCKOUT; PHENOTYPE; POINT MUTATION; SAPOSINS; SPINAL CORD;

MUS;

EID: 48049121251     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn135     Document Type: Article

References (51)

1. Rorman, E.G., Scheinker, V. and Grabowski, G.A. (1992) Structure and evolution of the human prosaposin chromosomal gene. Genomics, 13, 312-318.
2. O'Brien, J.S., Kretz, K.A., Dewji, N., Wenger, D.A., Esch, F. and Fluharty, A.L. (1988) Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus. Science, 241, 1098-1101.
3. Collard, M.W., Sylvester, S.R., Tsuruta, J.K. and Griswold, M.D. (1988) Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: Sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator. Biochemistry, 27, 4557-4564.
4. Nakano, T., Sandhoff, K., Stumper, J., Christomanou, H. and Suzuki, K. (1989) Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: Two alternate forms of the sulfatide activator. J. Biochem (Tokyo), 105, 152-154.
5. Vielhaber, G., Hurwitz, R. and Sandhoff, K. (1996) Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP)precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor. J. Biol. Chem., 271, 32438-32446.
6. Leonova, T., Qi, X., Bencosme, A., Ponce, E., Sun, Y. and Grabowski, G.A. (1996) Proteolytic processing patterns of prosaposin in insect and mammalian cells. J. Biol. Chem., 271, 17312-17320.
7. Hiraiwa, M., Martin, B.M., Kishimoto, Y., Conner, G.E., Tsuji, S. and O'Brien, J. S. (1997) Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): Its mechanism and inhibition by ganglioside. Arch. Biochem. Biophys., 341, 17-24.
8. Vaccaro, A.M., Salvioli, R., Barca, A., Tatti, M., Ciaffoni, F., Maras, B., Siciliano, R., Zappacosta, F., Amoresano, A. and Pucci, P. (1995) Structural analysis of saposin C and B. Complete localization of disulfide bridges. J. Biol. Chem., 270, 9953-9960.
9. Holtschmidt, H., Sandhoff, K., Kwon, H.Y., Harzer, K., Nakano, T. and Suzuki, K. (1991) Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J. Biol. Chem., 266, 7556-7560.
10. Rafi, M.A., de Gala, G., Zhang, X.L. and Wenger, D.A. (1993) Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency. Somat. Cell Mol. Genet., 19, 1-7.
11. Paton, B.C., Schmid, B., Kustermann-Kuhn, B., Poulos, A. and Harzer, K. (1992) Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase. Biochem. J., 285, 481-488.
12. Hulkova, H., Cervenkova, M., Ledvinova, J., Tochackova, M., Hrebicek, M., Poupetova, H., Befekada, A., Berna, L., Paton, B.C., Harzer, K. et al. (2001) A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum. Mol. Genet., 10, 927-940.
13. Harzer, K., Paton, B.C., Christomanou, H., Chatelut, M., Levade, T., Hiraiwa, M. and O'Brien, J.S. (1997) Saposins (sap) A and C activate the degradation of galactosylceramide in living cells. FEBS Lett., 417, 270-274.
14. Matsuda, J., Vanier, M.T., Saito, Y., Tohyama, J. and Suzuki, K. (2001) A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse. Hum. Mol. Genet., 10, 1191-1199.
15. Ciaffoni, F., Tatti, M., Boe, A., Salvioli, R., Fluharty, A., Sonnino, S. and Vaccaro, A.M. (2006) Saposin B binds and transfers phospholipids. J. Lipid Res., 47, 1045-1053.
16. Li, S.C., Sonnino, S., Tettamanti, G. and Li, Y.T. (1988) Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids. J. Biol. Chem., 263, 6588-6591.
17. Zhang, X.L., Rafi, M.A., DeGala, G. and Wenger, D.A. (1990) Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency. Proc. Natl. Acad. Sci. USA, 87 1426-1430.
18. Schnabel, D., Schroder, M. and Sandhoff, K. (1991) Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett., 284, 57-59.
19. Pampols, T., Pineda, M., Giros, M.L., Ferrer, I., Cusi, V., Chabas, A., Sanmarti, F.X., Vanier, M.T. and Christomanou, H. (1999) Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: Clinical course, neuropathology and brain lipid composition in this Gaucher disease variant. Acta Neuropathol. (Berl), 97, 91-97.
20. Azuma, N., O'Brien, J.S., Moser, H.W. and Kishimoto, Y. (1994) Stimulation of acid ceramidase activity by saposin D. Arch. Biochem. Biophys., 311, 354-357.
21. Matsuda, J., Kido, M., Tadano-Aritomi, K., Ishizuka, I., Tominaga, K., Toida, K., Takeda, E., Suzuki, K. and Kuroda, Y. (2004) Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Hum. Mol. Genet., 13, 2709-2723.
22. Li, C.M., Park, J.H., Simonaro, C.M., He, X., Gordon, R.E., Friedman, A.H., Ehleiter, D., Paris, F., Manova, K., Hepbildikler, S. et al. (2002) Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics, 79, 218-224.
23. Fujita, N., Suzuki, K., Vanier, M.T., Popko, B., Maeda, N., Klein, A., Henseler, M., Sandhoff, K. and Nakayasu, H. (1996) Targeted disruption of the mouse sphingolipid activator protein gene: A complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet., 5, 711-725.
24. Furst, W. and Sandhoff, K. (1992) Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim. Biophys. Acta, 1126 1-16.
25. Sandhoff, K., van Echten, G., Schroder, M., Schnabel, D. and Suzuki, K. (1992) Metabolism of glycolipids: The role of glycolipid-binding proteins in the function and pathobiochemistry of lysosomes. Biochem. Soc. Trans., 20, 695-699.
26. Ahn, V.E., Faull, K.F., Whitelegge, J.P., Fluharty, A.L. and Prive, G.G. (2003) Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl. Acad Sci. USA, 100, 38-43.
27. Zschoche, A., Furst, W., Schwarzmann, G. and Sanhoff, K. (1994) Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis. Eur. J. Biochem., 222 83-90.
28. Zhou, D., Cantu, C., III, Sagiv, Y., Schrantz, N., Kulkarni, A.B., Qi, X., Mahuran, D.J., Morales, C.R., Grabowski, G.A., Benlagha, K. et al. (2004) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science, 303, 523-527.
29. Yuan, W., Qi, X., Tsang, P., Kang, S.J., Illarionov, P.A., Besra, G.S., Gumperz, J. and Cresswell, P. (2007) Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc. Natl. Acad. Sci. USA, 104, 5551-5556.
30. Von Figura, K., Gieselmann, V. and Jacken, J. (2001) Metachromatic Leukodystrophy. Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (Eds), The Metabolic and Molecular Basis of Inherited Disease., 8th edn. McGraw-Hill, New York, Vol. III, pp. 3695-3724.
31. Sandhoff, K., Kolter, T. and Harzer, K. (2001) Sphingolipid Activator Proteins. Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (Eds), The Metabolic and Molecular Basis of Inherited Disease., 8th edn. McGraw-Hill, New York, Vol. III, pp. 3371-3388.
32. Deconinck, N., Messaaoui, A., Ziereisen, F., Kadhim, H., Sznajer, Y., Pelc, K., Cecile Nassogne, M., Vanier, M.T. and Dan, B. (2007) Metachromatic leukodystrophy without arylsulfatase A deficiency: A new case of saposin-B deficiency. Eur. J. Paediatr. Neurol.
33. Hess, B., Saftig, P., Hartmann, D., Coenen, R., Lullmann-Rauch, R., Goebel, H.H., Evers, M., von Figura, K., D'Hooge, R., Nagels, G. et al. (1996) Phenotype of arylsulfatase A-deficient mice: Relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci. USA, 93, 14821-14926.
34. Sun, Y., Witte, D.P., Zamzow, M., Ran, H., Quinn, B., Matsuda, J. and Grabowski, G.A. (2007) Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosyloeramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking. Hum. Mol. Genet., 16, 957-971.
35. Gordon, S., Lawson, L., Rabinowitz, S., Crocker, P.R., Morris, L. and Perry, V.H. (1992) Antigen markers of macrophage differentiation in murine tissues. Curr. Top Microbiol. Immunol., 181, 1-37.
36. Wrobe, D., Henseler, M., Huettler, S., Pascual Pascual, S.I., Chabas, A. and Sandhoff, K. (2000) A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD). J. Inherit. Metab. Dis., 23, 63-76.
37. Li, S.C., Kihara, H., Serizawa, S., Li, Y.T., Fluharty, A.L., Mayes, J.S. and Shapiro, L.J. (1985) Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide. J. Biol. Chem., 260, 1867-1871.
38. Xu, Y.H., Quinn, B., Witte, D. and Grabowski, G.A. (2003) Viable mouse models of acid beta-glucosidase deficiency: The defect in Gaucher disease. Am. J. Pathol., 163, 2093-2101.
39. Ioannou, Y.A., Zeidner, K.M., Gordon, R.E. and Desnick, R.I. (2001) Fabry disease: Preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am. J. Hum. Genet., 68, 14-25.
40. Ohshima, T., Murray, G.J., Swaim, W.D., Longenecker, G., Quirk, J.M., Cardarelli, C.O., Sugimoto, Y., Pastan, I., Gottesman, M.M., Brady, R.O. et al. (1997) alpha-Galactosidase A deficient mice: A model of Fabry disease. Proc. Natl. Acad. Sci. USA, 94, 2540-2544.
41. De Haas, C.G. and Lopes-Cardozo, M. (1995) Hydroxy- and non-hydroxy-galactolipids in developing rat CNS. Int. J. Dev. Neurosci., 13, 447-454.
42. Fewou, S.N., Bussow, H., Schaeren-Wiemers, N., Vanier, M.T., Macklin, W.B., Gieselmann, V. and Eckhardt, M. (2005) Reversal of non-hydroxy:aLpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:cEramide galactosyltransferase. J. Neurochem., 94, 469-481.
43. Eckhardt, M., Hedayati, K.K., Pitsch, J., Lullmann-Rauch, R., Beck, H., Fewou, S.N. and Gieselmann, V. (2007) Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy. J. Neurosci., 27, 9009-9021.
44. Tempesta, M.C., Salvayre, R. and Levade, T. (1994) Functional compartments of sulphatide metabolism in cultured living cells: Evidence for the involvement of a novel sulphatide-degrading pathway. Biochem. J., 297, 479-489.
45. Tybulewicz, V.L., Tremblay, M.L., LaMarca, M.E., Willemsen, R., Stubblefield, B.K., Winfield, S., Zablocka, B., Sidransky, E., Martin, B.M., Huang, S.P. et al. (1992) Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357, 407-410.
46. Phaneuf, D., Wakamatsu, N., Huang, J.Q., Borowski, A., Peterson, A.C., Fortunato, S.R., Ritter, G., Igdoura, S.A., Morales, C.R., Benoit G. et al. (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet., 5, 1-14.
47. Sun, Y., Quinn, B., Witte, D.P. and Grabowski, G.A. (2005) Gaucher disease mouse models: Point mutations at the acid (beta)-glucosidase locus combined with low-level prosaposin expression lead to disease variants. J. Lipid Res., 46, 2102-2113.
48. Sun, Y., Qi, X., Witte, D.P., Ponce, E., Kondoh, K., Quinn, B. and Grabowski, G.A. (2002) Prosaposin: Threshold rescue and analysis of the 'neuritogenic' region in transgenic, mice. Mol. Genet. Metab., 76, 271-286.
49. Han, X. and Gross, R.W. (2005) Shotgun lipidomics: Multidimensional MS analysis of cellular lipidomes. Expert Rev. Proteomics, 2, 253-264.
50. Jiang, X., Cheng, H., Yang, K., Gross, R.W. and Han, X. (2007) Alkaline methanolysis of lipid extracts extends shotgun lipidomics analyses to the low-abundance regime of cellular sphingolipids. Anal. Biochem. 371, 135-145.
51. Shimono, K., Baudry, M., Ho, L., Taketani, M. and Lynch, G. (2002) Long-term recording of LTP in cultured hippocampal slices. Neural. Plast., 9, 249-254.